The key executive appointment supports the strategic, operational delivery of the Company’s product and partnership programs.
Scorpion details early data on targeted breast cancer drug as it seeks to challenge Novartis, Roche
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS